CXCR4 blockade alleviates pulmonary and cardiac outcomes in early COPD
I. Dupin, P. Henrot, E. Maurat, R. Abohalaka, S. Chaigne, D. El Hamrani, E. Eyraud, R. Prevel, P. Esteves, M. Campagnac, M. Dubreuil, G. Cardouat, C. Bouchet, O. Ousova, J.-W. Dupuy, , P. Berger
This study shows that blocking CXCR4 improves lung and cardiac outcomes in early COPD using both human samples and mouse models.
bioRxiv · Mar 10, 2023Pathology